5Suppliers
0Customers
1Debt Items
12Related Chains

OKYO Pharma Limited Suppliers

TickerNameConfidenceEvidence
ON-TARGET-THERAPEUTICS-OTT ON-TARGET-THERAPEUTICS-OTT 92% License Agreement for Urcosimod On Target Therapeutics (OTT) and Tufts Medical Centre (TMC) entered into a license agreement on April 3, 2017
TUFTS-MEDICAL-CENTRE-TMC TUFTS-MEDICAL-CENTRE-TMC 92% License Agreement for Urcosimod On Target Therapeutics (OTT) and Tufts Medical Centre (TMC) entered into a license agreement on April 3, 2017
PANETTA-PARTNERS-LIMITED PANETTA-PARTNERS-LIMITED 90% On May 22, 2017, OTT entered into a license and sublicense agreement with Panetta Partners Limited, one of our principal stockholders
TMC TMC the metals company Inc. 90% We entered into a license agreement with TMC on May 1, 2018, relating to intellectual property and proprietary technology
TMC TMC the metals company Inc. 90% Reciprocal relationship from TMC graph: Reciprocal relationship from OKYO graph: Reciprocal relationship from TMC graph: Reciprocal relationship from OKYO graph: Reciprocal relationship from TMC grap…

OKYO Pharma Limited Customers

No clients on recordNo downstream customers found in our database for OKYO Pharma Limited.

OKYO Pharma Limited Debt Obligations

InstrumentDescriptionConfidenceEvidence
OKYO-DEBT Debt stack $185,795 90% Market cache reports total debt of $185,795.

OKYO Pharma Limited Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for OKYO Pharma Limited.

OKYO Pharma Limited Ownership

HolderNameConfidenceEvidence
OKYO-OWNER-WOODLINE-PARTNERS-LP Woodline Partners LP 90% 13F overlay lists Woodline Partners LP as top holder; 13 tracked holders.

OKYO Pharma Limited Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BMYMP Bristol-Myers Squibb Co 100.00 2
TMC TMC the metals company Inc. 100.00 1 ['supplier']
BMY Bristol-Myers Squibb Company 100.00 2
TLSA Tiziana Life Sciences Ltd 100.00 1 ['receiving', 'spend']
NNVC NanoViricides, Inc. 50.00 2
HEPA Hepion Pharmaceuticals, Inc. 38.88 1 ['receiving']
CRDF Cardiff Oncology, Inc. 38.88 1 ['receiving']
SIGA SIGA Technologies, Inc. 38.88 1 ['receiving']
IMRN Immuron Limited 38.88 1 ['receiving']
VKTX Viking Therapeutics, Inc. 14.78 2
MANU Manchester 14.78 2
CSLLY CSL Limited 14.78 2